Tenascin-C and integrins in cancer

被引：141
|
作者：
Yoshida, Toshimichi [1 ,2 ]
Akatsuka, Tatsuya [1 ]
Imanaka-Yoshida, Kyoko [1 ,2 ]
机构：
[1] Mie Univ, Grad Sch Med, Dept Pathol & Matrix Biol, Tsu, Mie 514, Japan
[2] Mie Univ, Res Ctr Matrix Biol, Tsu, Mie 514, Japan
来源：
CELL ADHESION & MIGRATION | 2015年 / 9卷 / 1-2期
关键词：
cancer cell; integrins; splice variant; Stromal cell; tenascin-C; EPITHELIAL-MESENCHYMAL TRANSITION; MESSENGER-RNA EXPRESSION; SQUAMOUS-CELL CARCINOMA; HUMAN BREAST-CANCER; GROWTH-FACTOR-BETA; SPLICE VARIANTS; ANNEXIN-II; PROTEIN DISTRIBUTION; ENDOTHELIAL-CELLS; COLORECTAL-CANCER;
D O I：
10.1080/19336918.2015.1008332
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Tenascin-C (TNC) is highly expressed in cancer tissues. Its cellular sources are cancer and stromal cells, including fibroblasts/myofibroblasts, and also vascular cells. TNC expressed in cancer tissues dominantly contains large splice variants. Deposition of the stroma promotes the epithelial-mesenchymal transition, proliferation, and migration of cancer cells. It also facilitates the formation of cancer stroma including desmoplasia and angiogenesis. Integrin receptors that mediate the signals of TNC have also been discussed.
引用
收藏
页码：96 / 104
页数：9
相关论文
共 50 条
  • [21] TENASCIN-C EXPRESSION IN ENDOMETRIOSIS
    Ulukus, Murat
    Ulukus, E. Cagnur
    Goker, Ege N. Tavmergen
    Zekioglu, Osman
    Gundem, Gursen
    Ulukus, Mustafa
    Tavmergen, Erol
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 2 (02) : 85 - 91
  • [22] Advances in tenascin-C biology
    Kim S. Midwood
    Thomas Hussenet
    Benoit Langlois
    Gertraud Orend
    Cellular and Molecular Life Sciences, 2011, 68 : 3175 - 3199
  • [23] Immunolocalization of Tenascin-C in Vitiligo
    Abdou, Asmaa Gaber
    Maraee, Alaa Hassan
    Shoeib, Mohamed Abd El-Monaem
    Elbana, Rania
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2012, 20 (05) : 501 - 511
  • [24] Inhibition of angiogenesis by a tenascin-C peptide which is capable of activating beta1-integrins
    Saito, Yohei
    Shiota, Yasuhiro
    Nishisaka, Mayuu
    Owaki, Toshiyuki
    Shimamura, Mariko
    Fukai, Fumio
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (05) : 1003 - 1007
  • [25] Tenascin-C mRNA and tenascin-C protein immunoreactivity increase in astrocytes after activation by bFGF
    Mahler, M
    Ferhat, L
    Gillian, A
    BenAri, Y
    Represa, A
    CELL ADHESION AND COMMUNICATION, 1996, 4 (03) : 175 - 186
  • [26] Clinical significance of tenascin-C expression in osteosarcoma: Tenascin-C promotes distant metastases of osteosarcoma
    Tanaka, M
    Yamazaki, T
    Araki, N
    Yoshikawa, H
    Yoshida, T
    Sakakura, T
    Uchida, A
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 5 (05) : 505 - 510
  • [27] Clinical significance of serum tenascin-C levels in breast cancer
    Tastekin, D.
    Tas, F.
    Karabulut, S.
    Duranyildiz, D.
    Serilmez, M.
    Guveli, M.
    Vatansever, S.
    TUMOR BIOLOGY, 2014, 35 (07) : 6619 - 6625
  • [28] Spatial organization of the tenascin-C microenvironment in experimental and human cancer
    Spenle, Caroline
    Gasser, Isabelle
    Saupe, Falk
    Janssen, Klaus-Peter
    Arnold, Christiane
    Klein, Annick
    van der Heyden, Michael
    Mutterer, Jerome
    Neuville-Mechine, Agnes
    Chenard, Marie-Pierre
    Guenot, Dominique
    Esposito, Irene
    Slotta-Huspenina, Julia
    Ambartsumian, Noona
    Simon-Assmann, Patricia
    Orend, Gertraud
    CELL ADHESION & MIGRATION, 2015, 9 (1-2) : 4 - 13
  • [29] Tenascin-C expression and its prognostic significance in colorectal cancer
    Lundin, M.
    Nordling, S.
    Lundin, J.
    Haglund, C.
    ONCOLOGY, 2007, 72 (5-6) : 403 - 409
  • [30] The value of Tenascin-C expression in neoadjuvant breast cancer therapy
    Bastelberger, Stephan
    Swierczynski, Stefan
    Pradel, Leon
    Beil, Jane
    Hinterseer, Elisabeth
    Rendi, Gundula
    Hauser-Kronberger, Cornelia
    Dietze, Otto
    CANCER RESEARCH, 2011, 71
12345